Stefan Schülke - Search Results

Year	Number of Results
2010	1
2011	1
2012	1
2014	2
2015	2
2016	3
2017	3
2018	7
2019	6
2020	1
2021	8
2022	6
2023	2

1

Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis.

Lin YJ, Anzaghe M, Schülke S. Lin YJ, et al. Among authors: schulke s. Cells. 2020 Apr 3;9(4):880. doi: 10.3390/cells9040880. Cells. 2020. PMID: 32260219 Free PMC article. Review.

2

The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota.

Blanco-Pérez F, Steigerwald H, Schülke S, Vieths S, Toda M, Scheurer S. Blanco-Pérez F, et al. Among authors: schulke s. Curr Allergy Asthma Rep. 2021 Sep 10;21(10):43. doi: 10.1007/s11882-021-01020-z. Curr Allergy Asthma Rep. 2021. PMID: 34505973 Free PMC article. Review.

3

Mouse Models for Food Allergies: Where Do We Stand?

Schülke S, Albrecht M. Schülke S, et al. Cells. 2019 Jun 6;8(6):546. doi: 10.3390/cells8060546. Cells. 2019. PMID: 31174293 Free PMC article. Review.

4

[Immunological background and pathomechanisms of food allergies].

Schülke S, Scheurer S. Schülke S, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Jun;59(6):723-31. doi: 10.1007/s00103-016-2346-3. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016. PMID: 27177897 Review. German.

5

Immune Metabolism of IL-4-Activated B Cells and Th2 Cells in the Context of Allergic Diseases.

Lin YJ, Goretzki A, Schülke S. Lin YJ, et al. Among authors: schulke s. Front Immunol. 2021 Dec 1;12:790658. doi: 10.3389/fimmu.2021.790658. eCollection 2021. Front Immunol. 2021. PMID: 34925372 Free PMC article. Review.

6

One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future.

Pfaar O, Creticos PS, Kleine-Tebbe J, Canonica GW, Palomares O, Schülke S. Pfaar O, et al. Among authors: schulke s. J Allergy Clin Immunol Pract. 2021 May;9(5):1791-1803. doi: 10.1016/j.jaip.2020.12.067. J Allergy Clin Immunol Pract. 2021. PMID: 33966868 Review.

7

Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy.

Anzaghe M, Schülke S, Scheurer S. Anzaghe M, et al. Among authors: schulke s. Curr Allergy Asthma Rep. 2018 Oct 25;18(12):71. doi: 10.1007/s11882-018-0827-1. Curr Allergy Asthma Rep. 2018. PMID: 30362017 Review.

8

Dendritic cell targeting with C-type lectins for improvement of allergen immunotherapy.

Schülke S, Vieths S. Schülke S, et al. J Allergy Clin Immunol. 2016 Aug;138(2):568-70. doi: 10.1016/j.jaci.2016.06.006. Epub 2016 Jun 23. J Allergy Clin Immunol. 2016. PMID: 27497282 No abstract available.

9

Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies.

Blanco-Pérez F, Papp G, Goretzki A, Möller T, Anzaghe M, Schülke S. Blanco-Pérez F, et al. Among authors: schulke s. Arch Immunol Ther Exp (Warsz). 2019 Oct;67(5):273-293. doi: 10.1007/s00005-019-00551-8. Epub 2019 Jun 20. Arch Immunol Ther Exp (Warsz). 2019. PMID: 31222414 Review.

10

Immune Metabolism-An Opportunity to Better Understand Allergic Pathology and Improve Treatment of Allergic Diseases?

Goretzki A, Zimmermann J, Lin YJ, Schülke S. Goretzki A, et al. Among authors: schulke s. Front Allergy. 2022 Mar 9;3:825931. doi: 10.3389/falgy.2022.825931. eCollection 2022. Front Allergy. 2022. PMID: 35386646 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results